Skip to content 
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts. more
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| ERNAW | |
|---|---|
| ROA (LTM) | -89.29% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| ERNAW | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
Ernexa Therapeutics Inc. Warrants (ERNAW) share price today is $0.0804
Yes, Indians can buy shares of Ernexa Therapeutics Inc. Warrants (ERNAW) on Vested. To buy
Yes, you can purchase fractional shares of Ernexa Therapeutics Inc. Warrants (ERNAW) via the Vested app. You can start investing in Ernexa Therapeutics Inc. Warrants (ERNAW) with a minimum investment of $1.
You can invest in shares of Ernexa Therapeutics Inc. Warrants (ERNAW) via Vested in three simple steps:
The 52-week high price of Ernexa Therapeutics Inc. Warrants (ERNAW) is $0.12. The 52-week low price of Ernexa Therapeutics Inc. Warrants (ERNAW) is $0.05.
The price-to-earnings (P/E) ratio of Ernexa Therapeutics Inc. Warrants (ERNAW) is
The price-to-book (P/B) ratio of Ernexa Therapeutics Inc. Warrants (ERNAW) is 0.00
The dividend yield of Ernexa Therapeutics Inc. Warrants (ERNAW) is 0.00%
The market capitalization of Ernexa Therapeutics Inc. Warrants (ERNAW) is
The stock symbol (or ticker) of Ernexa Therapeutics Inc. Warrants is ERNAW
Consider the share price of Ernexa Therapeutics Inc. Warrants as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Ernexa Therapeutics Inc. Warrants has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Ernexa Therapeutics Inc. Warrants shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Ernexa Therapeutics Inc. Warrants stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Ernexa Therapeutics Inc. Warrants and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Ernexa Therapeutics Inc. Warrants stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
